JANET BUTEL to Tumor Virus Infections
This is a "connection" page, showing publications JANET BUTEL has written about Tumor Virus Infections.
Connection Strength
6.498
-
Viral microRNA effects on pathogenesis of polyomavirus SV40 infections in syrian golden hamsters. PLoS Pathog. 2014 Feb; 10(2):e1003912.
Score: 0.422
-
Polyomavirus JC urinary shedding in kidney and liver transplant recipients associated with reduced creatinine clearance. J Infect Dis. 2012 Sep 15; 206(6):875-80.
Score: 0.379
-
Patterns of polyomavirus SV40 infections and associated cancers in humans: a model. Curr Opin Virol. 2012 Aug; 2(4):508-14.
Score: 0.378
-
Lymphotropism of Merkel cell polyomavirus infection, Nova Scotia, Canada. Emerg Infect Dis. 2010 Nov; 16(11):1702-9.
Score: 0.336
-
Variable frequency of polyomavirus SV40 and herpesvirus EBV in lymphomas from two different urban population groups in Houston, TX. J Clin Virol. 2009 Oct; 46(2):154-60.
Score: 0.308
-
SV40 lymphomagenesis in Syrian golden hamsters. Virology. 2009 Feb 05; 384(1):114-24.
Score: 0.294
-
Quantification of vertical transmission of Murine polyoma virus by real-time quantitative PCR. J Gen Virol. 2005 Oct; 86(Pt 10):2721-2729.
Score: 0.236
-
Frequent detection of polyomaviruses in stool samples from hospitalized children. J Infect Dis. 2005 Aug 15; 192(4):658-64.
Score: 0.233
-
Effects of radiation and latent virus on immune responses in a space flight model. J Allergy Clin Immunol. 2005 Jun; 115(6):1297-303.
Score: 0.231
-
Polyomavirus SV40 infections in Kazakhstan. J Infect. 2005 Feb; 50(2):142-8.
Score: 0.226
-
Re: Lack of serologic evidence for prevalent simian virus 40 infection in humans. J Natl Cancer Inst. 2004 Apr 21; 96(8):633; author reply 633-4.
Score: 0.214
-
SV40-positive brain tumor in scientist with risk of laboratory exposure to the virus. Oncogene. 2004 Mar 18; 23(12):2231-5.
Score: 0.213
-
Simian virus 40 in human cancers. Am J Med. 2003 Jun 01; 114(8):675-84.
Score: 0.201
-
Polyomavirus JCV excretion and genotype analysis in HIV-infected patients receiving highly active antiretroviral therapy. AIDS. 2003 Apr 11; 17(6):801-7.
Score: 0.199
-
Conventional epidemiology and the link between SV40 and human cancers. Lancet Oncol. 2003 Mar; 4(3):188-91.
Score: 0.198
-
Polyomaviruses in kidney transplant recipients. Am J Transplant. 2002 May; 2(5):481.
Score: 0.187
-
Detection of polyomavirus simian virus 40 tumor antigen DNA in AIDS-related systemic non-Hodgkin lymphoma. J Acquir Immune Defic Syndr. 2002 Feb 01; 29(2):109-16.
Score: 0.183
-
Increasing evidence for involvement of SV40 in human cancer. Dis Markers. 2001; 17(3):167-72.
Score: 0.170
-
Evidence of SV40 infections in hospitalized children. Hum Pathol. 1999 Dec; 30(12):1496-502.
Score: 0.158
-
Molecular evidence of simian virus 40 infections in children. J Infect Dis. 1999 Sep; 180(3):884-7.
Score: 0.155
-
Polyomaviruses and human tumors: a brief review of current concepts and interpretations. Front Biosci. 1999 Feb 15; 4:D153-64.
Score: 0.149
-
Cell and molecular biology of simian virus 40: implications for human infections and disease. J Natl Cancer Inst. 1999 Jan 20; 91(2):119-34.
Score: 0.149
-
Natural isolates of simian virus 40 from immunocompromised monkeys display extensive genetic heterogeneity: new implications for polyomavirus disease. J Virol. 1998 May; 72(5):3980-90.
Score: 0.141
-
Serological evidence of SV40 infections in HIV-infected and HIV-negative adults. J Med Virol. 1998 Apr; 54(4):276-84.
Score: 0.141
-
Detection of authentic SV40 DNA sequences in human brain and bone tumours. Dev Biol Stand. 1998; 94:23-32.
Score: 0.138
-
A coupled PCR and restriction digest method for the detection and analysis of the SV40 regulatory region in infected-cell lysates and clinical samples. J Virol Methods. 1997 Feb; 64(1):1-9.
Score: 0.130
-
Specific Antibodies Reacting with SV40 Large T Antigen Mimotopes in Serum Samples of Healthy Subjects. PLoS One. 2016; 11(1):e0145720.
Score: 0.120
-
A system for the analysis of BKV non-coding control regions: application to clinical isolates from an HIV/AIDS patient. Virology. 2010 Nov 25; 407(2):368-73.
Score: 0.083
-
Detection of polyomavirus SV40 in tonsils from immunocompetent children. J Clin Virol. 2008 Sep; 43(1):66-72.
Score: 0.071
-
SV40 multiple tissue infection and asbestos exposure in a hyperendemic area for malignant mesothelioma. Cancer Res. 2007 Sep 15; 67(18):8456-9.
Score: 0.068
-
A prospective longitudinal study of polyomavirus shedding in lung-transplant recipients. J Infect Dis. 2007 Feb 01; 195(3):442-9.
Score: 0.064
-
Lymphoproliferative disorders in Costa Rica and simian virus 40. Haematologica. 2005 Dec; 90(12):1635-42.
Score: 0.060
-
Emergent human pathogen simian virus 40 and its role in cancer. Clin Microbiol Rev. 2004 Jul; 17(3):495-508, table of contents.
Score: 0.054
-
Polyomavirus simian virus 40 infection associated with nephropathy in a lung-transplant recipient. Transplantation. 2004 Apr 15; 77(7):1019-24.
Score: 0.053
-
Re: Trends in U.S. pleural mesothelioma incidence rates following simian virus 40 contamination of early poliovirus vaccines. J Natl Cancer Inst. 2003 May 07; 95(9):687; author reply 689.
Score: 0.050
-
Association between SV40 and non-Hodgkin's lymphoma. Leuk Lymphoma. 2003; 44 Suppl 3:S33-9.
Score: 0.049
-
Simian virus 40, poliovirus vaccines, and human cancer: research progress versus media and public interests. Bull World Health Organ. 2000; 78(2):195-8.
Score: 0.040
-
Evidence of simian virus 40 exposure in a colony of captive baboons. Virology. 2008 Jul 20; 377(1):54-62.
Score: 0.018